Mumbai, Aug. 12 -- Revenue for the period under review was Rs 1,702.3 crore, down 10% YoY. The company has recorded 12% volume growth and 3% revenue growth in the domestic business, with biologicals recording aggressive growth. Pricing remained under pressure and delayed monsoon has led to partial postponment of sales.

Agchem exports dropped by 12% in value terms and by 8% in volume terms, primarily due to soft demand in global agrochemical industry. PI Health Sciences (PIHS) revenue fell by 25% YoY mainly due to customer order phasing.

Total operating expenditure fell by 3.4% to Rs 1,334.90 crore in Q1 FY27 over Q1 FY26, as lower raw material costs (down 10% YoY) more than offset higher finished goods purchases (up 25.1% YoY) and highe...